COVID‐19 pneumonia in a patient with sarcoidosis: A case report

Key prognostic elements to consider in sarcoidosis patients who contract COVID‐19 pneumonia are pulmonary involvement, the underlying immune system dysfunction, immunosuppressive therapies’ use, and the increased risk for hypercoagulability.

Detalles Bibliográficos
Autores principales: Ramdani, Hanae, Benelhosni, Khadija, Moatassim Billah, Nabil, Nassar, Ittimade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869356/
https://www.ncbi.nlm.nih.gov/pubmed/33598270
http://dx.doi.org/10.1002/ccr3.3684
Descripción
Sumario:Key prognostic elements to consider in sarcoidosis patients who contract COVID‐19 pneumonia are pulmonary involvement, the underlying immune system dysfunction, immunosuppressive therapies’ use, and the increased risk for hypercoagulability.

Ejemplares similares